Limiting gadolinium use may avert renal systemic fibrosis, says study

Following the adoption of restrictive guidelines for gadolinium-based contrast agent administration, no new nephrogenic systemic fibrosis cases have been identified in contrast-enhanced magnetic resonance examinations, even in patients with a low estimated glomerular filtration rate, according to a study published in Radiology. Yingbing Wang, M.D., from Massachusetts General Hospital in Boston, and colleagues compared the incidence of NSF before and after the adoption of restrictive GBCA administration guidelines in 2007. The guidelines limited the maximum GBCA dose to 20 mL in patients with low eGFR (60 mL/min/m


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top